Hailing Yu

Hailing Yu

Auto-generated profile, based on publicly available information

Hailing Yu

Guangdong Provincial Engineering Research Center of Molecular Imaging, Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, No. 52 of Meihuadong Road, Xiangzhou District, Zhuhai, Guangdong, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2020 in Nanoscale
Verified
Journal Article
Closed access
PDF file
YHYu Hailing
Yu Hailing
LXLv Xiufang
Lv Xiufang
WLWu Lili
Wu Lili
Baoqiang LiBaoqiang Li
Baoqiang Li
HKHuang Kaichen
Huang Kaichen
SHShan Hong
Shan Hong
In this work, we reported a novel and effective cancer treatment strategy by fabricating carbon dot (CD)-polyethylenimine (PEI)-doxorubicin (DOX) antitumor drug complexes from a combination of PEI-passivated CDs (CD-PEI) and DOX. CD-PEI was synthesized by the one-step microwave hydrothermal carbonization of a mixture of glycerol and PEI-25k, enabling simultaneous synthesis and surface passivation of CDs. DOX was loaded onto CD-PEI by electrostatic interactions. The results show that this system not only improves selective drug release but also prolongs the drug release time and improves the killing effect on tumors. Compared with free DOX, the CD-PEI-DOX complex has a stronger killing effect on liver cancer cells (MHCC-97L and Hep3B cells) but a very low killing effect on normal liver cells (L02). Studies have also confirmed that compared with DOX alone, CD-PEI-DOX nanoparticles can effectively inhibit tumors because of the larger amount of drugs localized in tumor cells and the higher apoptosis rate of MHCC-97L cells. In vivo experiments confirmed that CD-PEI-DOX has a stronger inhibitory effect on tumor growth, indicating that CD-PEI-DOX nanomedicine has inhibitory effects on tumors.

1 June 2012 in Transactions of Nonferrous Metals Society of China
Verified
Journal Article
Closed access
ZNZhi-Sheng Nong
Zhi-Sheng Nong
JZJingchuan Zhu
Jingchuan Zhu
HYHai-Ling Yu
Hai-Ling Yu
ZLZhong-Hong Lai
Zhong-Hong Lai

15 September 2016 in Small
Verified
Journal Article
Closed access
PDF file
HYHailing Yu
Hailing Yu
AKAndrii Kopach
Andrii Kopach
VMVyacheslav Misko
Vyacheslav Misko
AVAnna A. Vasylenko
Anna A. Vasylenko
DMDenys Makarov
Denys Makarov
Gianaurelio CunibertiGianaurelio Cuniberti
Gianaurelio Cuniberti

1 January 2020 in Journal of Cancer
Verified
Journal Article
Open access
XHXiaopeng Hong
Xiaopeng Hong
HLHui Luo
Hui Luo
GZGenglong Zhu
Genglong Zhu
Xiaodong GuanXiaodong Guan
Xiaodong Guan
YJYingbin Jia
Yingbin Jia
JLJian Li
Jian Li
Background: Hepatocellular carcinoma (HCC) is a common malignancy around the world. The molecular mechanisms underlying HCC tumorigenesis and metastasis are far from clear. Numerous studies have pointed out that signal sequence receptor (SSR) is an endoplasmic reticulum-related protein involved in protein folding and processing of eukaryotic cells. SSR2 is a subunit of SSR protein, but the role of SSR2 in hepatocellular carcinoma is largely unknown and warrants further study.

28 January 2025 in Biomaterials
Verified
Journal Article
Closed access
YCYanlv Chen
Yanlv Chen
WMWanru Meng
Wanru Meng
HYHailing Yu
Hailing Yu
CHChuandong He
Chuandong He
MYMeng Yu
Meng Yu
XPXin Peng
Xin Peng

1 December 2015 in Materials & Design
Verified
Journal Article
Closed access
HYHailing Yu
Hailing Yu
JZJiaqi Zhu
Jiaqi Zhu
LYLei Yang
Lei Yang
BDBing Dai
Bing Dai
Larysa BarabanLarysa Baraban
Larysa Baraban
JHJiecai Han
Jiecai Han